Microbio Co., Ltd. (TPEX:4128)

Microbio Statistics

Total Valuation

Microbio has a market cap or net worth of TWD 8.47 billion. The enterprise value is 7.54 billion.

Market Cap	8.47B
Enterprise Value	7.54B

Important Dates

The next estimated earnings date is Monday, August 10, 2026.

Earnings Date	Aug 10, 2026
Ex-Dividend Date	n/a

Share Statistics

Microbio has 588.17 million shares outstanding.

Current Share Class	588.17M
Shares Outstanding	588.17M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	1.84%
Owned by Institutions (%)	3.55%
Float	422.88M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	4.37
PB Ratio	0.85
P/TBV Ratio	1.00
P/FCF Ratio	67.26
P/OCF Ratio	50.18
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-10.90
EV / Sales	3.89
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	59.90

Financial Position

The company has a current ratio of 5.76, with a Debt / Equity ratio of 0.07.

Current Ratio	5.76
Quick Ratio	5.07
Debt / Equity	0.07
Debt / EBITDA	n/a
Debt / FCF	5.13
Interest Coverage	-36.22

Financial Efficiency

Return on equity (ROE) is -8.77% and return on invested capital (ROIC) is -5.52%.

Return on Equity (ROE)	-8.77%
Return on Assets (ROA)	-2.18%
Return on Invested Capital (ROIC)	-5.52%
Return on Capital Employed (ROCE)	-3.85%
Weighted Average Cost of Capital (WACC)	6.53%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.15
Inventory Turnover	4.98

Taxes

In the past 12 months, Microbio has paid 1.96 million in taxes.

Income Tax	1.96M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -40.00% in the last 52 weeks. The beta is 0.48, so Microbio's price volatility has been lower than the market average.

Beta (5Y)	0.48
52-Week Price Change	-40.00%
50-Day Moving Average	16.02
200-Day Moving Average	19.99
Relative Strength Index (RSI)	38.66
Average Volume (20 Days)	1,751,387

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Microbio had revenue of TWD 1.94 billion and -691.94 million in losses. Loss per share was -1.18.

Revenue	1.94B
Gross Profit	773.55M
Operating Income	-440.77M
Pretax Income	-926.14M
Net Income	-691.94M
EBITDA	-342.34M
EBIT	-440.77M
Loss Per Share	-1.18

Balance Sheet

The company has 2.83 billion in cash and 645.68 million in debt, with a net cash position of 2.19 billion or 3.72 per share.

Cash & Cash Equivalents	2.83B
Total Debt	645.68M
Net Cash	2.19B
Net Cash Per Share	3.72
Equity (Book Value)	9.92B
Book Value Per Share	14.72
Working Capital	2.75B

Cash Flow

In the last 12 months, operating cash flow was 168.77 million and capital expenditures -42.85 million, giving a free cash flow of 125.92 million.

Operating Cash Flow	168.77M
Capital Expenditures	-42.85M
Depreciation & Amortization	98.44M
Net Borrowing	-171.97M
Free Cash Flow	125.92M
FCF Per Share	0.21

Margins

Gross margin is 39.89%, with operating and profit margins of -22.73% and -35.68%.

Gross Margin	39.89%
Operating Margin	-22.73%
Pretax Margin	-47.76%
Profit Margin	-35.68%
EBITDA Margin	-17.65%
EBIT Margin	-22.73%
FCF Margin	6.49%

Dividends & Yields

Microbio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-8.17%
FCF Yield	1.49%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on August 29, 2024. It was a forward split with a ratio of 1.049999998.

Last Split Date	Aug 29, 2024
Split Type	Forward
Split Ratio	1.049999998

Scores

Microbio has an Altman Z-Score of 3.88 and a Piotroski F-Score of 4.

Altman Z-Score	3.88
Piotroski F-Score	4